BioVie Inc. | Balance Sheet

Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
332.90
267.50
123.80
5.10
45.80
Other Current Assets
-
2.00
7.00
-
-
Total Current Assets
332.90
269.50
130.70
5.10
45.80
Intangible Assets
-
-
2,588.40
2,359.10
2,129.70
Total Assets
332.90
269.50
2,719.20
2,364.20
2,175.50
ST Debt & Current Portion LT Debt
-
-
10.00
35.00
Other Current Liabilities
161.50
323.60
793.20
596.00
Total Current Liabilities
161.50
323.60
803.20
631.00
Other Liabilities
-
-
-
575.90
Total Liabilities
161.50
323.60
803.20
1,206.90
Common Equity (Total)
171.40
54.10
1,915.90
1,157.30
Total Shareholders' Equity
171.40
54.10
1,915.90
1,157.30
Total Equity
171.40
54.10
1,915.90
1,157.30
Liabilities & Shareholders' Equity
332.90
269.50
2,719.20
2,364.20

About BioVie

View Profile
Address
2120 Colorado Avenue
Santa Monica California 90404
United States
Employees -
Website http://www.biovieinc.com
Updated 07/08/2019
BioVie, Inc. is a development stage biotechnology company. The company engages in the discovery, development and commercialization of antibiotics for gram-negative and gram-positive bacterial infections. BioVie was founded on April 10, 2013 and is headquartered in Beverly, MA.